Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Gordon ReidLiquidiaLQDATOP PICKMar 10, 2026

A small company involved in a rare lung disease, PAH. He made money off a similar situation in United Therapeutics, but LQDA has a better drug that is taking share from UT. So, he switched horses.

(Analysts’ price target is $53.75)
$38.83

Stock price when the opinion was issued

$71.23

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.